Danaher Corporation (NYSE: DHR), a provider of industrial and medical products, reported higher sales and net profit for the fourth quarter of 2022. Fourth
Earnings Infographic: Highlights of Danaher Corporation’s (DHR) Q4 results
Categories
pharmaceuticals
JNJ Earnings: All you need to know about Johnson & Johnson’s Q4 2022 earnings results
Johnson & Johnson (NYSE: JNJ) reported its fourth quarter 2022 earnings results today. Reported sales decreased 4.4% year-over-year to $23.7 billion. Net
Cadrenal Therapeutics downsizes IPO, looks to raise $7 million
There has been an increase in the number of pharma companies taking the IPO route to enhance their research and development activities
Trxade Health Inc. (NASDAQ: MEDS) Q4 2022 Research Summary
Trxade Health Inc. (NASDAQ: MEDS), an integrated drug procurement and delivery platform, is on a mission to empower the independent pharmacy market
Nava Health to go public with a $12Mln IPO. Here’s all you need to know
With only a few days left for 2022 to end, there aren't many initial public offerings scheduled for the rest of the
Cancer drug maker Felicitex prepares for IPO. Here’s all you need to know
Fewer companies filed for initial public offering this year, compared to 2021 when the market witnessed a record number of IPOs. With
Catalyst Pharmaceuticals Inc (CPRX) Q3 2022 Earnings Call Transcript
Catalyst Pharmaceuticals Inc (NASDAQ:CPRX) Q3 2022 Earnings Call dated Nov. 10, 2022. Corporate Participants: Alicia Grande -- Vice President, Chief Financial Officer and Treasurer
ANI Pharmaceuticals Inc (ANIP) Q3 2022 Earnings Call Transcript
ANI Pharmaceuticals Inc (NASDAQ:ANIP) Q3 2022 Earnings Call dated Nov. 09, 2022. Corporate Participants: Judy DiClemente -- Investor Relations Nikhil Lalwani -- President and Chief Executive
PetIQ Inc (PETQ) Q3 2022 Earnings Call Transcript
PetIQ Inc (NASDAQ:PETQ) Q3 2022 Earnings Call dated Nov. 09, 2022. Corporate Participants: Katie Turner -- Investor Relations Executive McCord Christensen -- Chief Executive Officer
Jazz Pharmaceuticals PLC (JAZZ) Q3 2022 Earnings Call Transcript
Jazz Pharmaceuticals PLC (NASDAQ:JAZZ) Q3 2022 Earnings Call dated Nov. 09, 2022. Corporate Participants: Andrea N. Flynn -- Vice President, Head, Investor Relations Bruce
Perrigo Co PLC (PRGO) Q3 2022 Earnings Call Transcript
Perrigo Co PLC (NYSE:PRGO) Q3 2022 Earnings Call dated Nov. 08, 2022. Corporate Participants: Bradley Joseph -- Vice President, Global Investor Relations and Corporate
Earnings: Trxade Health (MEDS) reports 6% drop in Q3 revenue; loss narrows
Trxade Health Inc (NASDAQ: MEDS), a leading health service IT company, reported a modest decline in its third-quarter revenues. Meanwhile, the company's
Zoetis Inc (ZTS) Q3 2022 Earnings Call Transcript
Zoetis Inc (NYSE:ZTS) Q3 2022 Earnings Call dated Nov. 03, 2022. Corporate Participants: Steve Frank -- Vice President of Investor Relations Kristin Peck -- Chief Executive
Consider these factors before investing in Eli Lilly and Company (LLY)
The stock performance of Eli Lilly and Company (NYSE: LLY) has been exceptionally good this year, with the pharma giant defying the
Eli Lilly and Company (LLY) Q3 2022 Earnings Call Transcript
Eli Lilly and Company (NYSE:LLY) Q3 2022 Earnings Call dated Nov. 01, 2022. Corporate Participants: Joe Fletcher -- Senior Vice President, Investor Relations David
Four noteworthy points from Pfizer’s (PFE) Q3 2022 earnings report
Shares of Pfizer Inc. (NYSE: PFE) were up 3% on Tuesday after the company beat estimates for the third quarter of 2022
Earnings: Highlights of Eli Lilly’s (LLY) Q3 2022 results
Eli Lilly and Company (NYSE: LLY) on Tuesday reported higher earnings and revenues for the third quarter of 2022. The company also
Pfizer (PFE) Q3 2022 Earnings: Key financials and quarterly highlights
Pfizer Inc. (NYSE: PFE) reported third quarter 2022 earnings results today. Revenues decreased 6% year-over-year to $22.6 billion. Reported net income increased
ABBV Infographic: AbbVie’s Q3 earnings beat estimates; revenue up 3%
Pharmaceutical company AbbVie, Inc. (NYSE: ABBV) reported a sharp increase in third-quarter adjusted earnings. The bottom line topped expectations, while revenues missed.
Infographic: Highlights of Merck’s (MRK) Q3 2022 earnings
Merck & Co., Inc. (NYSE: MRK) reported a modest increase in adjusted earnings for the third quarter of 2022 when the pharmaceutical
BIIB Stock: Is Biogen an investment worth trying now?
Biogen Inc. (NASDAQ: BIIB) has been going through a rough patch for some time as the company's popular products faced competition and